USFDA Approves Sun Pharma's Alopecia Areata Drug - LEQSELVI

By By Rediff Money Desk, New Delhi
Jul 26, 2024 10:53
Sun Pharma's LEQSELVI (deuruxolitinib) receives USFDA approval for treating severe alopecia areata in adults. This new drug offers hope for patients with this autoimmune disorder causing hair loss.
Photograph: Francis Mascarenhas/Reuters
New Delhi, Jul 26 (PTI) Sun Pharmaceutical Industries Ltd on Friday said the US health regulatory has approved its LEQSELVI (deuruxolitinib) drug for the treatment of adults with severe alopecia areata.

The approval by the US Food and Drug Administration (USFDA) is for LEQSELVI (deuruxolitinib) 8 mg tablets, Sun Pharma said in a regulatory filing.

Alopecia areata is an autoimmune disorder that can lead to unpredictable hair loss. It occurs when the immune system mistakenly targets hair follicles on the scalp, face, and sometimes other parts of the body, due to a breakdown in immune privilege.

"LEQSELVI offers a new and effective solution that will significantly enhance options for long-suffering patients battling severe alopecia areata and their physicians," Sun Pharma CEO, North America Business, Abhay Gandhi said.

The approval is based on data from two multicenter, randomised, double-blind, placebo-controlled Phase 3 clinical trials which enrolled a total of 1,220 patients with alopecia areata who had at least 50 per cent scalp hair loss as measured by Severity of Alopecia Tool (SALT) for more than six months, the company said.
Source: PTI
Read More On:
sun pharmausfdatreatmenthair lossalopecia areatahair follicledeuruxolitinibleqselviautoimmune disorder
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Samsung Galaxy S25: India Manufacturing, AI...

Samsung's new Galaxy S25 series will be manufactured in India, boasts enhanced AI...

Maharashtra Inks Rs 15 Lakh Cr MoUs at Davos

Maharashtra government signs 54 MoUs worth Rs 15.70 lakh crore at Davos, including a Rs...

Karnataka Unveils New Industrial, EV Policies...

Karnataka will announce new industrial, EV and clean mobility policies at the Karnataka...

Responsible AI Challenges: HCLTech-MIT Study

HCLTech and MIT study reveals challenges in adopting responsible AI, highlighting...

Go Digit Q3 Net Profit Soars 3-fold to Rs 119...

Go Digit's net profit for Q3 FY25 surged by almost 300% to Rs 119 crore, driven by...

India's Digital Potential: Key to Inclusive...

KPMG report highlights India's digital potential for inclusive growth and becoming a...

JSW UAV to Set Up Rs 800 Crore Facility in...

JSW UAV Ltd. has signed an MoU with the Telangana government to establish a...

India Aims for 10,000 GI Products by 2030

India's Commerce Minister sets an ambitious target to register 10,000 Geographical...

Wadhawan Port: India Aims for Top 10 Container...

Union Minister Sonowal highlights Wadhawan Port's potential to elevate India to the top...

HUDCO Q3 Net Profit Surges 42% to Rs 735 Cr

HUDCO's consolidated net profit for the December quarter rose 42% to Rs 735.03 crore,...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com